ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Application of UV phototherapy in the treatment of psoriasis

Psoriasis, is a chronic, recurrent, inflammatory and systemic skin disease caused by genetic and environmental effects.Psoriasis in addition to the skin symptoms, there will also be cardiovascular, metabolic, digestive and malignant tumors and other multi-system diseases. Although it is not infectious, it mainly hurts the skin and has a great impact on the appearance, which brings great physical and psychological burden to the patients and seriously affects the quality of life.

So, how does ultraviolet phototherapy treat psoriasis?

1. The conventional treatment of psoriasis

 Topical drugs are the main treatment for mild to moderate psoriasis. The treatment of topical drugs depends on the patient's age, history, type of psoriasis, course of disease and lesions.

 Commonly used drugs are glucocorticoids, vitamin D3 derivatives, retinoic acid and so on. Systemic use of oral drugs or biologics such as methotrexate, cyclosporine and retinoic acid is recommended for patients with scalp psoriasis accompanied by moderate to severe lesions.

 2. The characteristics of ultraviolet phototherapy

 Ultraviolet phototherapy is a more recommended treatment for psoriasis in addition to drugs. Phototherapy mainly induces the apoptosis of T cells in psoriatic lesions, thus inhibiting the overactivated immune system and promoting the regression of lesions.

 It mainly includes BB-UVB(>280~320nm), NB-UVB(311±2nm), PUVA(oral, medicinal bath and local) and other treatments.The curative effect of NB-UVB was better than BB-UVB and weaker than PUVA in UV treatment of psoriasis. However, NB-UVB is the most commonly used ultraviolet treatment with high safety and convenient use. Topical UV treatment is recommended when the skin area is less than 5% of the total body surface area.When the skin area is greater than 5% of the body surface area, systemic UV treatment is recommended.

 3. NB-UVB treatment of psoriasis

 In the treatment of psoriasis, the main effective band of UVB is in the range of 308~312nm. The effective band of NB-UVB(311±2nm) in the treatment of psoriasis is more pure than that of BB-UVB(280~320nm), and the effect is better, close to the effect of PUVA, and reduces the erythematous reaction caused by the ineffective band. Good safety, no association with skin cancer was found. At present, NB-UVB is the most popular clinical application in the treatment of psoriasis.

article source: https://www.yonkermed.com/news/application-of-uv-phototherapy-in-the-treatment-of-psoriasis/

Media Contact
Company Name: Xuzhou Yongkang Electronic Science Technology Co., Ltd.
Email: Send Email
Country: China
Website: https://www.yonkermed.com/


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.